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targeted interventions to improve prescribing practices and
patient safety.
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OBJECTIVES: High prices and poor availability of medicines are
major barriers to better health in poor countries. In India, more
than 80% of health care expenditure is “out-of-pocket”. The
study was undertaken to assess medicines prices and the avail-
ability of essential medicines in Rajasthan State, India.
METHODS: Price and availability data for 36 medicines were
measured using a methodology developed by WHO and Health
Action International (HAI). For each medicine, data was col-
lected for the Innovator Brand (IB), Most Sold Generic (MSG),
and Lowest Priced Generic (LPG). In each of four randomly
selected regions, ﬁve public facilities, ﬁve private retail and ﬁve
co-operative pharmacies were surveyed. Prices were compared to
an international reference benchmark (expressed as Median Price
Ratios-MPR). RESULTS: In the public sector, generic medicines
were purchased and provided free of charge to various categories
of people. Procurement prices were reasonable (median MPR
0.96) but the median availability was only 40%. In the private
sector, the median MPR for IB, MSG and LPG was 2.81, 2.72
and 1.83 respectively. The median availability was 0% for IBs,
82.5% for MSGs and 95% for LPGs. Prices in the co-operative
sector were similar to the private pharmacies, but the availabil-
ity was lower. In the private sector, the MPR for three medicines
(LPG) were 8 to 26 times higher than the government procure-
ment prices, indicating very high margins for wholesalers and
retailers. CONCLUSIONS: As the availability of medicines in
the public sector is low, people have to purchase medicines in
the private sector, many of which are high in price. This base-
line survey shows that the Indian government needs to imple-
ment policies to increase the availability of medicines in the
public sector and reduce prices in the private sector.
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OBJECTIVE: Hispanic consumers who do not speak English
may have difﬁculty in interpreting information provided on
Over-the-Counter (OTC) medication labels. This study devel-
oped bilingual Product Information Labels (PILs) for OTCs and
compared them to existing OTC labels. METHODS: The study
had a randomized-within subjects design. Three hundred and
thirty-six consumers, from pharmacy stores in Houston, TX,
participated in the study. Participants were selected randomly
and they viewed, in a random order, each label format for aceta-
minophen, ibuprofen and aspirin. Each label was followed by a
questionnaire for participants. Consumers were divided into
three language categories, namely, only English-speaking, only
Spanish-speaking and bilinguals. Variables measured on the
questionnaire were ease of use, product knowledge, attitude
towards product label, product evaluation and purchase inten-
tion. Data were coded and analyzed using the SAS statistical
package (Version 9.0). Descriptive and comparative statistics
were computed for each variable as well as for all label formats.
RESULTS: Means obtained for PILs were signiﬁcantly different
from those obtained for old and new formats (p < 0.05) for all
consumer categories. A majority of participants were very certain
that they understood the information on PILs (68.15%) and
were very satisﬁed (74.11%) that they understood this informa-
tion shown on the package label. Moreover, about 85% of 
participants who used the Spanish language information on 
PILs found it very useful. CONCLUSIONS: Bilingual PILs, 
as compared existing label formats, are an effective means of 
providing information to all Hispanic consumers. These results
may help the FDA in developing policies to enhance the safety
of OTC medication used for the large Hispanic population in the
USA.
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OBJECTIVES: Donabedian described client satisfaction as “the
ultimate validator” of quality in health care. Identify items in the
Medicare Current Beneﬁciary Survey (MCBS)—-2002 as mea-
sured by satisfaction regarding health care access that correlate
with satisfaction with quality of care. This is the ﬁrst step in
developing a new model that relates health care access to health
care quality as measured by consumer/patient satisfaction.
METHODS: Access items from the survey were measured by a
4-point satisfaction scale: 1 = very satisﬁed to 4 = very dissatis-
ﬁed. Only responses on the 1 to 4 scale were used; all other
responses or non-responses were considered as missing data. The
missing data then were imputed employing the EM algorithm;
complete cases were used in the analysis (N = 16,087). A linear
regression model by weighted least squares using the one-year
cross-sectional weights from the MCBS is done using items in
the survey, measured by satisfaction, that correspond to Pen-
chansky and Thomas’ ﬁve dimensions of health care access-
accessibility, acceptability, accommodation, affordability, and
availability- and are regressed on the dependent variable
MCQUALTY (satisfaction with medical care received in last
year). RESULTS: The regression model identiﬁed sixteen of 20
eligible items that signiﬁcantly correlated (p < 0.05) to satisfac-
tion with quality of care in the Medicare population of 2002.
CONCLUSIONS: Health care access and quality of care as mea-
sured by satisfaction have signiﬁcant correlation in the Medicare
population.
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The Saudi Arabian Ministry of Health (MOH) controls the uti-
lization of the free pharmacy beneﬁt program (PBP) by having a
closed universal formulary and ensures the effectiveness of the
PBP by instituting a pharmacy & therapeutics (P&T) committee
in each hospital. OBJECTIVES: To test the relationship among
the levels of development P&T committees and patients’ access
rates to prescription drugs. METHODS: A cross-sectional
descriptive survey design was conducted in the ﬁrst phase and
covered 127 MOH pharmacy managers at non-specialized hos-
pitals. The survey gathered information about: hospital, phar-
macy, and P&T committee characteristics. The survey results
were used to classify the MOH hospitals according to the levels
of development of the P&T committee. In the second phase, the
prescription audit phase, hospitals deliberately were selected
based on the hospitals’ P&T committee levels of development.
From each hospital, 150 patient records were systematically
sampled and patient’s access rate was calculated for each patient.
Analysis of variance (ANOVA) was used to test the existence of
a signiﬁcant difference in the access rates across the levels of
development of P&T committee. RESULTS: Of 127 MOH hos-
pitals, 81 (63.7%) hospitals were valid for the analysis. Of 81
hospitals, 13, 24, 39, 5 hospitals have undeveloped, poorly, par-
tially, and developed P&T committees, respectively. A total of
6885 prescription drugs were prescribed for 2850 patients in 19
audited hospitals. The overall rate for patients’ access was
97.3%. The ANOVA tests for the existence of a signiﬁcant dif-
ference of access rates across the levels of development of P&T
committee showed mixed results. CONCLUSIONS: The positive
relationship between the levels of development of P&T commit-
tee and patient’s access to prescription drugs was not conclusive.
However, the ﬁnding might be due to lack of enough data and
controls of other confounding variables rather than inexistence
of the relationship.
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OBJECTIVES: A newly developed 90-day retail-dispensing
program allows members to obtain 90-day supplies of mainte-
nance medications through a retail pharmacy stores at a discount
co-payment. The objective of this study is to investigate if there
is any relationship between generic utilization observed in pre-
scriptions dispensed through this channel and members’ co-pay
difference between brand and generic medications. METHODS:
The analysis was conducted using pharmacy claim data obtained
from a pharmacy beneﬁt management organization. Clients
included in the analysis were those who implemented the 90-day
retail program from January 2004 to July 2004 and also allowed
its members to obtain prescriptions through both 90-day mail
and 30-day retail channels. The relationship between generic uti-
lization and co-pay structure was assessed using multiple regres-
sion analysis. The dependent variable was proportion of generic
prescription claims dispensed through 90-day retail channel. The
independent variables were ratio of brand to generic cost, the
absolute co-pay amount difference between brand and generic
medications, age, gender, and prior generic utilization of 90-day
mail as well as 30-day retail program. RESULTS: A total of 25
clients were included in the analysis. In 90-day retail program,
the generic utilization ranged from 21.5% to 77.5%, ratio of
brand to generic cost varied from 1.9 to 6.2, and absolute co-
pay amount difference between brand and generic medications
varied from $11.2 to $101.5. A linear, positive relationship was
observed between generic utilization and ratio of brand to
generic cost (P < 0.05). Previous 90-day mail generic utilization
was also found to have positive impact on the 90-day retail
generic utilization (P < 0.05). CONCLUSIONS: Study results
indicate an increase in co-pay difference between brand and
generic medications do have a positive impact on 90-day retail
generic utilization. Further investigation is needed to test the
relationship between co-pay structure and generic utilization
among different channels.
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OBJECTIVE: STEPS is a structured model for the selection of
drugs for formulary inclusion. The aim of this study was to use
the STEPS model in the selection of statin products for use within
a health board in Northern Ireland. METHODS: The STEPS
model involved three phases in sequence: an evidence based
pharmacotherapeutic evaluation of all available statin drug enti-
ties in the UK, a separate safety/risk assessment analysis of
product lines of drug entities which exceeded the pharma-
cotherapeutic threshold and ﬁnally a budget impact analysis. A
